Holen Sie sich die Stockscreener-App
2.26
1.74%
-0.04
Handel nachbörslich:
2.26
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMRA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$2.30
Offen:
$2.32
24-Stunden-Volumen:
11,393
Relative Volume:
0.17
Marktkapitalisierung:
$10.37M
Einnahmen:
$4.33M
Nettoeinkommen (Verlust:
$-4.17M
KGV:
-1.5114
EPS:
-1.4953
Netto-Cashflow:
$-3.19M
1W Leistung:
-13.24%
1M Leistung:
+8.13%
6M Leistung:
+6.60%
1J Leistung:
-20.14%
1-Tages-Spanne:
$2.2509
$2.34
1-Wochen-Bereich:
$2.18
$2.64
52-Wochen-Spanne:
$1.45
$3.2133
Biomerica Inc Stock (BMRA) Company Profile
Firmenname
Biomerica Inc
Sektor
Branche
Telefon
(949) 379-2875
Adresse
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
2.26 | 10.65M | 4.33M | -4.17M | -3.19M | -1.4953 |
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-10 | Eingeleitet | Colliers Securities | Buy |
| 2018-01-04 | Eingeleitet | B. Riley FBR, Inc. | Buy |
Biomerica Inc Aktie (BMRA) Neueste Nachrichten
Biomerica May Offer Up To $250 Million Of Common Stock, Preferred Stock, Debt Securities, & Warrants - TradingView
Biomerica Files $250 Million Mixed Shelf - marketscreener.com
An audit raises substantial doubt Biomerica (BMRA) can stay in business as it registers securities for possible sale. - Stock Titan
Form S-3 Biomerica Inc For: 24 September By Investing.com - Investing.com Australia
Form S-3 Biomerica Inc For: 24 September - Investing.com India
Biomerica files prospectus for resale of 1.4 million shares - scanx.trade
Biomerica Stock Price Forecast. Should You Buy BMRA? - StockInvest.us
Biomerica Inc. (BMRA) Holds Near $2.36 as Traders Eye Tight RangeDiamond Pattern - siam.in
Biomerica (BMRA) gets new B. Riley-linked shareholder - stocktitan.net
Biomerica (BMRA) finance chief discloses four stock option awards - Stock Titan
Biomerica Raises $2.23 Million as Quarterly Sales Rise 17% - Orange County Business Journal
Biomerica Inc. (BMRA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Biomerica (BMRA) Gains 1.35% as Shares Test Key Level Near $2.36Cash Secured Put - dars.gov.et
BRC Group Holdings, Inc. Buys Biomerica Inc (BMRA) -- Shares Loo - GuruFocus
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com India
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock - Investing.com
Biomerica net loss hits USD 3.8M in 2026 - Medical Buyer
BRC Group Holdings Secures 10.03% Activist Stake in BIOMERICA INC (NASDAQ: BMRA) with $736,128 Investment - Kalkine Media
Biomerica reports fiscal 2026 revenue and product updates - grafa.com
Biomerica Reports Q4 Results - Orange County Business Journal
Biomerica Q4 net loss narrows 27%, revenue up 17% to $875K - scanx.trade
Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization - Quiver Quantitative
Biomerica Inc. (BMRA) Key Financial Ratios – Valuation, Profitability & More - Value Research
Biomerica Inc. (BMRA) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
BIOMERICA INC FY 2026: Revenue $4.45M, EPS $(1.30) — 10-K Summary - TradingView
Biomerica : Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K) - marketscreener.com
Biomerica announces USD 2.23M financing - medicalbuyer.co.in
Biomerica, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Biomerica Inc. (BMRA) Peer Comparison – Compare with Others - Value Research
B. Riley joins Biomerica (BMRA) as key investor and deal advisor - Stock Titan
Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com Canada
Biomerica (BMRA) director joins $1.60 private placement buy - Stock Titan
Biomerica (BMRA) director adds 6,250 shares in private deal - Stock Titan
Biomerica (NASDAQ: BMRA) director adds shares in $1.60 private placement - Stock Titan
Biomerica (NASDAQ: BMRA) director lifts stake to 73,542 shares - Stock Titan
Biomerica (NASDAQ: BMRA) CEO adds 31,250 shares in private placement - Stock Titan
Biomerica raises $2.23M in private placement led by B. Riley - Dealroom
Biomerica raises $2.23 million in private placement at $1.60 - Investing.com
Biomerica Announces $2.23 Million Private Placement at $1.60 per Share and Engages B. Riley to Review Strategic Alternatives - Moomoo
Biomerica commences $2.23M private placement of 1.394M shares at $1.60 - scanx.trade
Biomerica, Inc. Hires B. Riley to Consider Strategic Options - marketscreener.com
Biomerica Completes Private Placement of Equity Securities - TipRanks
Biomerica Enters Securities Purchase Agreement for Private Placement With Investors - TradingView
Biomerica (NASDAQ: BMRA) grants B. Riley board designee in $2.23M raise - Stock Titan
Biomerica, Inc. announced that it has received $2.229928 million in funding - marketscreener.com
Biomerica (BMRA) Chart: Ends Up by 4.35% at $1.68; Range View: the Current Price Sits Inside the Supplied Technical Range in the Latest ReadingQuote Data - vinanet.vn
Biomerica (BMRA) Watch: Moves 1.58% Higher to $1.61 in Latest Trading; Immediate View: the Supplied Trading Band Runs From $1.53 to $1.69 in the Available RecordIchimoku Kumo Twist - vinanet.vn
Biomerica, Inc. announced that it expects to receive $2.229928 million in funding - marketscreener.com
BMRA Q2 2026 Earnings: EPS Loss of $0.44 Highlights Cost-Heavy Development PhaseEarnings Season Review - vinanet.vn
Biomerica (BMRA) Slips 2.47% to $1.58 as Shares Test Key Support ZonePassive Flow - dars.gov.et
Finanzdaten der Biomerica Inc-Aktie (BMRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Biomerica Inc-Aktie (BMRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MOATAZEDI DAVID | Director |
Aug 26 '26 |
Buy |
1.60 |
10,000 |
16,000 |
40,625 |
| Chin Eric | Director |
Aug 26 '26 |
Buy |
1.60 |
6,250 |
10,000 |
38,750 |
| BARBIERI ALLEN | Executive Vice Chairman |
Aug 26 '26 |
Buy |
1.60 |
20,000 |
32,000 |
73,542 |
| Irani Zackary S. | Chief Executive Officer |
Aug 26 '26 |
Buy |
1.60 |
31,250 |
50,000 |
242,570 |
2.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):